Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 5487

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 10973

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 16460

Details

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The G8 countries contributed USD 654.1 billion in 2017 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 5.5% between 2013 and 2017. The G8 countries are expected to reach a value of USD 851.7 billion in 2022, with a CAGR of 5.4% over the 2017-22 period.

- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of USD 401.0 billion in 2017. This was followed by Germany and Japan, with a value of USD 71.3 and USD 68.2 billion, respectively.

- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of USD 552.0 billion in 2016, followed by Germany and Japan with expected values of USD 90.5 and USD 70.1 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market

- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts

- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

- What was the size of the G8 pharmaceuticals market by value in 2017?

- What will be the size of the G8 pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the G8 pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the G8 pharmaceuticals market?

READ MORE

Table Of Content

Scope

Table of Contents

Introduction 14

What is this report about? 14

Who is the target reader? 14

How to use this report 14

Definitions 14

Group of Eight (G8) Pharmaceuticals 15

Industry Outlook 15

Pharmaceuticals in Canada 19

Market Overview 19

Market Data 20

Market Segmentation 21

Market outlook 23

Five forces analysis 24

Macroeconomic indicators 33

Pharmaceuticals in France 35

Market Overview 35

Market Data 36

Market Segmentation 37

Market outlook 39

Five forces analysis 40

Macroeconomic indicators 48

Pharmaceuticals in Germany 50

Market Overview 50

Market Data 51

Market Segmentation 52

Market outlook 54

Five forces analysis 55

Macroeconomic indicators 64

Pharmaceuticals in Italy 66

Market Overview 66

Market Data 67

Market Segmentation 68

Market outlook 70

Five forces analysis 71

Macroeconomic indicators 80

Pharmaceuticals in Japan 82

Market Overview 82

Market Data 83

Market Segmentation 84

Market outlook 86

Five forces analysis 87

Macroeconomic indicators 96

Pharmaceuticals in Russia 98

Market Overview 98

Market Data 99

Market Segmentation 100

Market outlook 102

Five forces analysis 103

<

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Company Profile

Company Profile Title

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The G8 countries contributed USD 654.1 billion in 2017 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 5.5% between 2013 and 2017. The G8 countries are expected to reach a value of USD 851.7 billion in 2022, with a CAGR of 5.4% over the 2017-22 period.

- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of USD 401.0 billion in 2017. This was followed by Germany and Japan, with a value of USD 71.3 and USD 68.2 billion, respectively.

- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of USD 552.0 billion in 2016, followed by Germany and Japan with expected values of USD 90.5 and USD 70.1 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market

- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts

- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

- What was the size of the G8 pharmaceuticals market by value in 2017?

- What will be the size of the G8 pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the G8 pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the G8 pharmaceuticals market?

READ MORE

Scope

Table of Contents

Introduction 14

What is this report about? 14

Who is the target reader? 14

How to use this report 14

Definitions 14

Group of Eight (G8) Pharmaceuticals 15

Industry Outlook 15

Pharmaceuticals in Canada 19

Market Overview 19

Market Data 20

Market Segmentation 21

Market outlook 23

Five forces analysis 24

Macroeconomic indicators 33

Pharmaceuticals in France 35

Market Overview 35

Market Data 36

Market Segmentation 37

Market outlook 39

Five forces analysis 40

Macroeconomic indicators 48

Pharmaceuticals in Germany 50

Market Overview 50

Market Data 51

Market Segmentation 52

Market outlook 54

Five forces analysis 55

Macroeconomic indicators 64

Pharmaceuticals in Italy 66

Market Overview 66

Market Data 67

Market Segmentation 68

Market outlook 70

Five forces analysis 71

Macroeconomic indicators 80

Pharmaceuticals in Japan 82

Market Overview 82

Market Data 83

Market Segmentation 84

Market outlook 86

Five forces analysis 87

Macroeconomic indicators 96

Pharmaceuticals in Russia 98

Market Overview 98

Market Data 99

Market Segmentation 100

Market outlook 102

Five forces analysis 103

<

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies